Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 17/20 | 0.71 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16114849 | 0.83 | TACR3 (1.00) | TACR3KCNH2CYP2C9CYP2C19P2RX7 | |
| SCHEMBL107638 | 0.82 | TACR3 (0.63) | TACR3KCNH2CYP2C9CYP2C19P2RX7 | |
| SCHEMBL107757 | 0.82 | P2RX7 (0.66) | TACR3P2RX7 | |
| SCHEMBL110280 | 0.81 | P2RX7 (0.56) | TACR3KCNH2P2RX7 | |
| SCHEMBL111176 | 0.79 | P2RX7 (0.68) | TACR3KCNH2P2RX7 | |
| SCHEMBL108944 | 0.77 | P2RX7 (0.68) | TACR3P2RX7 | |
| SCHEMBL25607204 | 0.75 | TACR3 (0.70) | TACR3KCNH2CYP2C9CYP2C19P2RX7 | |
| SCHEMBL17850264 | 0.75 | P2RX7 (0.53) | TACR3KCNH2P2RX7 | |
| SCHEMBL108491 | 0.75 | P2RX7 (0.67) | P2RX7 | |
| SCHEMBL107226 | 0.75 | P2RX7 (0.57) | P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2424869-B1 | 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS | GLAXO GROUP LTD (GB) | 2016-06-22 | — | — | EP | claimed |